In 2015 HD researchers started a small sample of clinical trials in California on individuals who were recently diagnosed with HD. The 1st clinical trial was to test the safety of the medication and the 2nd trial was to test if the medication treated what it was suppose to treat which was to stop the progression of HD symptoms. What are the latest updates on the 2 trials?